HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alogliptin

structure in first source
Also Known As:
2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl) benzonitrile; SYR 322; SYR-322; SYR322; nesina
Networked: 279 relevant articles (42 outcomes, 115 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. White, William B: 19 articles (07/2021 - 10/2011)
2. Zannad, Faiez: 16 articles (07/2021 - 10/2011)
3. Cannon, Christopher P: 15 articles (01/2020 - 10/2011)
4. Bakris, George L: 11 articles (01/2020 - 10/2011)
5. Cushman, William C: 9 articles (08/2018 - 10/2011)
6. Seino, Yutaka: 9 articles (05/2017 - 09/2011)
7. Mehta, Cyrus R: 8 articles (08/2018 - 10/2013)
8. Kupfer, Stuart: 8 articles (01/2018 - 10/2013)
9. Wilson, Craig A: 8 articles (01/2018 - 12/2008)
10. Fleck, P: 8 articles (01/2016 - 01/2010)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Insulin Resistance
3. Hypoglycemia (Reactive Hypoglycemia)
4. Non-alcoholic Fatty Liver Disease
5. Albuminuria

Related Drugs and Biologics

1. Metformin (Glucophage)
2. Pioglitazone (Actos)
3. Dipeptidyl-Peptidase IV Inhibitors
4. Insulin (Novolin)
5. Glucose (Dextrose)
6. saxagliptin
7. Hypoglycemic Agents (Hypoglycemics)
8. Glucagon-Like Peptide 1 (GLP 1)
9. Incretins
10. Sitagliptin Phosphate (Januvia)

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Renal Dialysis (Hemodialysis)
4. Aftercare (After-Treatment)
5. Cardiac Resynchronization Therapy